Targeted Therapeutics & Nanoparticles
A key objective of pharmaceutical and biopharmaceutical development is to increase product therapeutic specificity and safety. Some of the recent exciting developments have obviously been related to the development in new chemical entities for the treatment of underserved disease populations. However, increasingly, successful developments in this field involve new formulation technologies that use engineered physic-chemical attributes to enable and improve the efficacy and safety of new and existing products. These formulation technologies can positively affect product specificity, bioavailability, biodistribution, pharmacokinetics and safety. Click here for more.
Total Page Views: 523
